The global lacrimal devices market size surpassed USD 159.25 million in 2023 and is estimated to increase from USD 165.19 million in 2024 to approximately USD 238.24 million by 2034. It is projected to grow at a CAGR of 3.73% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Lacrimal Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Lacrimal Devices Market Revenue and Volume, by Product, 2024-2034
8.1.1 Intubation Sets
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Tubes
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Stents
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Cannula & Spatula
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Dilator
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1.6. Punctal Plugs
8.1.6.1. Market Revenue and Volume Forecast (2021-2034)
8.1.7. Others
8.1.7.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Lacrimal Devices Market Revenue and Volume, by Application, 2024-2034
9.1.1. Dry Eye
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Glaucoma
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Epiphora
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Drainage Obstruction
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1.5. Lacrimal Gland Inflammation
9.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1.6. Others
9.1.6.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Lacrimal Devices Market Revenue and Volume, by End-use, 2024-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Ophthalmic Clinics
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Diagnostic Centers
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)
12.1. Walsh Medical Devices Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. JEDMED
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Braintree Scientific
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Kaneka Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bess Medical Technology GmbH
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Rumex International Co
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Lacrimedics Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. BVI
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Meddenium
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. FCI Ophthalmic
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample